EST Cathie Wood’s ARK Investment buys 77.6K shares of 10x Genomics (TXG) today Published first on TheFly – the ultimate source for ...
Zacks.com on MSN14h
10x Genomics (TXG) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseGenomics (TXG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
February 05, 2025, 03:25 AM ET, BY Thomas H. Kee Jr, Editor, Stock Traders Daily | Editor: Derek Curry ( Follow on LinkedIn ) ...
James reiterated its Outperform rating and Cdn$34.00 price target for Torex Gold Resources (TXG:CN) (OTC: OTC:TORXF). The firm's analyst highlighted the company's significant progress on its Media ...
Construction substantially complete and first copper concentrate on track for March (All amounts expressed in U.S. dollars ...
Genomics (TXG – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Michael Ryskin from ...
In a report released today, Michael Ryskin from Bank of America Securities maintained a Hold rating on 10x Genomics (TXG – Research Report).
View 10x Genomics, Inc. (TXG) current and estimated P/E ratio data provided by Seeking Alpha.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback